In the News
LACRIFILL® Canalicular Gel is changing clinical practice and changing lives when it comes to dry eye treatment. Latest NewsNordic Group B.V. through its subsidiary Amring Pharmaceuticals Inc., appoints ophthalmology innovator, Eric D. Donnenfeld, MD as Medical Advisory Board Chair
Nordic Group B.V. through its subsidiary Amring Pharmaceuticals Inc., announces Jai G. Parekh, MD, MBA as Chief Commercial Officer, Eye Care U.S.
Nordic Pharma Group B.V. through its subsidiary Amring Pharmaceuticals Inc., completes acquisition of Visant Medical to launch novel therapy for dry eye disease in The United States
Come meet with us at these 2026 Meetings and Conferences
ASCRS
April 10–13
Washington D.C.
Vision Source Exchange
April 29–May 2
Nashville, TN
AAO
October 10–12
New Orleans, LA